[A report on clinical trials with the oral antidiabetic SH 717 (Redul) of the Bayer-Schering firm].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged
D001786:Blood Glucose; D007004:Hypoglycemic Agents
Bericht über die klinische Prüfung des peroralen Antidiabetikums SH 717 (Redul) der Firmen Bayer-Schering.